Celcuity Inc. CELC
Set alert
69.13 USD -0.17 -0.25%
At close · Oct 30
69.29 +0.16 +0.23%
After hours · Oct 30, 4:09 PM ET
67.42 Day range 70.43
56.58 52-week range 144.98
- YTD
- -30.69%
- 1 year
- -12.45%
- Open
- 68.47
- Prev close
- 69.30
- Mkt cap
- 3.38B
- Vol
- 700.08K
- Avg vol
- 1.18M
- EPS
- -4.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 67.42
- High
- 70.43
- Forward P/E
- -864.13
- Beta
- 0.11
- Short ratio
- 7.39
- Inst. own
- 112.68%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 78.10
- 200-d avg
- 100.86
- 1y target
- 154.72
MAX chart
Events in this range
- Aug 14, 2025Earnings: -1.04; estimate -0.9; surprise -15.56%
- Nov 12, 2025Earnings: -0.92; estimate -1.02; surprise 9.8%
- Mar 25, 2026Earnings: -0.97; estimate -1.06; surprise 8.49%
- May 14, 2026Earnings: -0.97; estimate -1.04; surprise 6.73%
- Aug 13, 2026Earnings: -1.44; estimate -1.16; surprise -24.14%
- Aug 17, 2026Rating: Citizens · Market Outperform → Market Outperform
- Aug 17, 2026Rating: Guggenheim · Buy → Buy
- Sep 17, 2026Rating: JP Morgan · — → Overweight
- Sep 30, 2026Rating: Needham · Buy → Buy
- Oct 21, 2026Rating: TD Cowen · Buy → Buy
- Oct 22, 2026Rating: Cantor Fitzgerald · — → Overweight
- Nov 5, 2026Earnings: —; estimate -1.5; surprise —%
Signals (149)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 11, 2026 | 5 months ago |
| RSI: Overbought | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| RSI: Overbought | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| RSI: Overbought | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 24, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 17, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Jan 6, 2025 | 1 year ago |
| SMA: Bullish | Dec 23, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Nov 4, 2024 | 1 year ago |
| SMA: Bearish | Oct 28, 2024 | 2 years ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| SMA: Bearish | Aug 26, 2024 | 2 years ago |
| SMA: Bearish | Aug 26, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 22, 2024 | 2 years ago |
| SMA: Bullish | Jun 24, 2024 | 2 years ago |
| SMA: Bullish | Jun 24, 2024 | 2 years ago |
| SMA: Bearish | May 20, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| RSI: Overbought | Feb 26, 2024 | 2 years ago |
| RSI: Overbought | Nov 27, 2023 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 23, 2023 | 3 years ago |
| SMA: Bullish | Oct 9, 2023 | 3 years ago |
| SMA: Bearish | Sep 25, 2023 | 3 years ago |
| SMA: Bearish | Sep 18, 2023 | 3 years ago |
| SMA: Bullish | Sep 11, 2023 | 3 years ago |
| SMA: Bullish | Sep 11, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 10, 2023 | 3 years ago |
| SMA: Bearish | Jul 3, 2023 | 3 years ago |
| SMA: Bearish | Jul 3, 2023 | 3 years ago |
| MACD: Buy Signal | May 29, 2023 | 3 years ago |
| SMA: Bullish | May 22, 2023 | 3 years ago |
| SMA: Bullish | May 15, 2023 | 3 years ago |
| SMA: Bearish | Mar 13, 2023 | 3 years ago |
| SMA: Bearish | Mar 13, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 13, 2023 | 3 years ago |
| SMA: Bullish | Mar 6, 2023 | 3 years ago |
| SMA: Bullish | Feb 6, 2023 | 3 years ago |
| SMA: Bullish | Feb 6, 2023 | 3 years ago |
| MACD: Buy Signal | Feb 6, 2023 | 3 years ago |
| SMA: Bearish | Jan 30, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 30, 2023 | 3 years ago |
| SMA: Bearish | Jan 23, 2023 | 3 years ago |
| RSI: Overbought | Dec 26, 2022 | 3 years ago |
| MACD: Buy Signal | Dec 19, 2022 | 3 years ago |
| SMA: Bullish | Dec 12, 2022 | 3 years ago |
| SMA: Bullish | Dec 5, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 28, 2022 | 3 years ago |
| SMA: Bearish | Nov 21, 2022 | 3 years ago |
| SMA: Bullish | Sep 26, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| SMA: Bullish | May 30, 2022 | 4 years ago |
| MACD: Buy Signal | May 23, 2022 | 4 years ago |
| RSI: Oversold | Apr 18, 2022 | 4 years ago |
| RSI: Oversold | Mar 7, 2022 | 4 years ago |
| RSI: Oversold | Jan 17, 2022 | 4 years ago |
| SMA: Bearish | Nov 8, 2021 | 4 years ago |
| SMA: Bullish | Nov 1, 2021 | 5 years ago |
| SMA: Bearish | Aug 30, 2021 | 5 years ago |
| SMA: Bullish | Aug 23, 2021 | 5 years ago |
| SMA: Bearish | Aug 16, 2021 | 5 years ago |
| SMA: Bullish | Aug 9, 2021 | 5 years ago |
| SMA: Bearish | Jul 26, 2021 | 5 years ago |
| SMA: Bearish | Jun 28, 2021 | 5 years ago |
| MACD: Sell Signal | Jun 28, 2021 | 5 years ago |
| SMA: Bullish | Jun 21, 2021 | 5 years ago |
| RSI: Overbought | Jun 21, 2021 | 5 years ago |
| SMA: Bearish | Jun 14, 2021 | 5 years ago |
| SMA: Bullish | Apr 5, 2021 | 5 years ago |
| MACD: Buy Signal | Apr 5, 2021 | 5 years ago |
| RSI: Overbought | Apr 5, 2021 | 5 years ago |
| MACD: Sell Signal | Mar 29, 2021 | 5 years ago |
| SMA: Bearish | Mar 22, 2021 | 5 years ago |
| SMA: Bullish | Mar 15, 2021 | 5 years ago |
| SMA: Bearish | Mar 1, 2021 | 5 years ago |
| RSI: Overbought | Jan 18, 2021 | 5 years ago |
| SMA: Bullish | Nov 9, 2020 | 5 years ago |
| SMA: Bullish | Oct 26, 2020 | 6 years ago |
| SMA: Bearish | Oct 12, 2020 | 6 years ago |
| SMA: Bullish | Sep 14, 2020 | 6 years ago |
| SMA: Bearish | Jun 22, 2020 | 6 years ago |
| SMA: Bearish | Jun 8, 2020 | 6 years ago |
| SMA: Bullish | May 18, 2020 | 6 years ago |
| SMA: Bullish | May 18, 2020 | 6 years ago |
| MACD: Buy Signal | May 4, 2020 | 6 years ago |
| MACD: Sell Signal | Mar 9, 2020 | 6 years ago |
| RSI: Oversold | Feb 24, 2020 | 6 years ago |
| SMA: Bearish | Feb 10, 2020 | 6 years ago |
| MACD: Buy Signal | Jan 20, 2020 | 6 years ago |
| SMA: Bullish | Jan 13, 2020 | 6 years ago |
| RSI: Oversold | Nov 18, 2019 | 6 years ago |
| MACD: Sell Signal | Aug 5, 2019 | 7 years ago |
| SMA: Bearish | Jul 22, 2019 | 7 years ago |
| SMA: Bearish | Jul 22, 2019 | 7 years ago |
| SMA: Bullish | Jun 24, 2019 | 7 years ago |
| SMA: Bullish | Jun 17, 2019 | 7 years ago |
| SMA: Bearish | May 27, 2019 | 7 years ago |
| SMA: Bearish | May 27, 2019 | 7 years ago |
| SMA: Bullish | May 20, 2019 | 7 years ago |
| MACD: Buy Signal | Apr 29, 2019 | 7 years ago |
| SMA: Bullish | Apr 22, 2019 | 7 years ago |
| SMA: Bearish | Apr 15, 2019 | 7 years ago |
| MACD: Sell Signal | Apr 15, 2019 | 7 years ago |
| MACD: Buy Signal | Apr 8, 2019 | 7 years ago |
| SMA: Bullish | Mar 25, 2019 | 7 years ago |
| SMA: Bearish | Feb 25, 2019 | 7 years ago |
| SMA: Bullish | Feb 11, 2019 | 7 years ago |
| SMA: Bearish | Dec 3, 2018 | 7 years ago |
| SMA: Bearish | Nov 5, 2018 | 7 years ago |
| MACD: Sell Signal | Nov 5, 2018 | 7 years ago |
| SMA: Bullish | Oct 15, 2018 | 8 years ago |
| SMA: Bearish | Oct 8, 2018 | 8 years ago |
| SMA: Bullish | Sep 10, 2018 | 8 years ago |
| MACD: Buy Signal | Sep 10, 2018 | 8 years ago |
| SMA: Bearish | Sep 3, 2018 | 8 years ago |
| MACD: Sell Signal | Sep 3, 2018 | 8 years ago |
| RSI: Overbought | Aug 13, 2018 | 8 years ago |
| RSI: Overbought | Jun 18, 2018 | 8 years ago |
| SMA: Bullish | Apr 23, 2018 | 8 years ago |
| SMA: Bearish | Apr 16, 2018 | 8 years ago |
| SMA: Bullish | Apr 2, 2018 | 8 years ago |
| SMA: Bearish | Jan 29, 2018 | 8 years ago |
| RSI: Overbought | Jan 1, 2018 | 8 years ago |
Key statistics
- Market cap
- 3.38B
- Enterprise value
- 3.39B
- Trailing P/E
- 0.00
- Forward P/E
- -864.13
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -4.31
- Beta
- 0.11
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -72.00M
- Total cash
- 754.04M
- Total debt
- 754.39M
- Return on equity
- -1433.70%
- Shares outstanding
- 48.93M
- Short % of float
- 31.43%
- 50-day average
- 78.10
- 200-day average
- 100.86
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 154.72 +123.8% upside
Now 69.13
- Target (low)
- 130.00
- Target (mean)
- 154.72
- Target (high)
- 177.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
- Strong buy3
- Buy10
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate -1.51.
Financials — quick view
CELC Revenue — quarterly 0
CELC Net income — quarterly -78.86M
CELC EPS — quarterly -1.44
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | -1.50 | — | — | — |
| Aug 13, 2026 | Jun 30, 2026 | -1.16 | -1.44 | -0.28 | -24.14% |
| May 14, 2026 | Mar 31, 2026 | -1.04 | -0.97 | +0.07 | +6.73% |
| Mar 25, 2026 | Dec 31, 2025 | -1.06 | -0.97 | +0.09 | +8.49% |
| Nov 12, 2025 | Sep 30, 2025 | -1.02 | -0.92 | +0.10 | +9.80% |
| Aug 14, 2025 | Jun 30, 2025 | -0.90 | -1.04 | -0.14 | -15.56% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 22, 2026 | Cantor Fitzgerald | init | — | Overweight |
| Oct 21, 2026 | TD Cowen | reit | Buy | Buy |
| Sep 30, 2026 | Needham | main | Buy | Buy |
| Sep 17, 2026 | JP Morgan | init | — | Overweight |
| Aug 17, 2026 | Guggenheim | main | Buy | Buy |
| Aug 17, 2026 | Citizens | reit | Market Outperform | Market Outperform |
About Celcuity Inc.
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- celcuity.com
News
- Celcuity: Stronger Clinical Evidence, Much Lower Valuation
- Celcuity Schedules Release of Third Quarter 2026 Financial Results and Webcast/Conference Call
- Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026
- Celcuity Presents Updated Data from a Phase 1b/2 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration-Resistant Prostate Cancer at the ESMO Congress 2026
- Cantor Fitzgerald Initiates Coverage On Celcuity with Overweight Rating, Announces Price Target of $140
- New Strong Sell Stocks for October 14th
- Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026
- Celcuity Appoints David Gryska To Its Board Of Directors
- Celcuity (NASDAQ:CELC) Shares Gap Up – Time to Buy?
- Why Celcuity Stock Was a Winner on Wednesday
Your note
Sign in to keep a note on CELC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAKER BROS ADVISORS L.P. | Unknown | Sale | Jul 13, 2026 | 0 |
| BULLER RICHARD E | Director | Stock Award(Grant) | Jun 4, 2026 | 9,319 |
| DALVEY DAVID F | Director | Stock Award(Grant) | Jun 4, 2026 | 66,530 |
| FURCHT LEO M.D. | Director | Stock Award(Grant) | Jun 4, 2026 | 12,530 |
| HAHNE VICKY | Chief Financial Officer | Stock Award(Grant) | Aug 13, 2026 | 37,808 |
| LAING LANCE G PH.D. | Officer and Director | Stock Award(Grant) | Aug 13, 2026 | 1,271,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Baker Bros. Advisors, LP | 16.18% | 7,915,792 | 547.22M | Jun 29, 2026 |
| Avoro Capital Advisors LLC | 6.95% | 3,400,000 | 235.04M | Jun 29, 2026 |
| RTW Investments LP | 6.75% | 3,304,903 | 228.47M | Jun 29, 2026 |
| Perceptive Advisors Llc | 6.53% | 3,197,200 | 221.02M | Jun 29, 2026 |
| Blackrock Inc. | 6.17% | 3,018,785 | 208.69M | Jun 29, 2026 |
| State Street Corporation | 4.00% | 1,955,304 | 135.17M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.85% | 1,394,056 | 96.37M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.45% | 1,197,169 | 82.76M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.04% | 996,070 | 68.86M | Sep 29, 2026 |
| Manager Directed Portfolios-Hood River Small-Cap Growth Fund | 1.32% | 648,060 | 44.80M | Jul 30, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 0.98% | 479,203 | 33.13M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.89% | 436,212 | 30.16M | Jun 29, 2026 |